|
Model Number SENSH2428W |
Device Problems
Fluid/Blood Leak (1250); Device Damaged by Another Device (2915)
|
Patient Problems
Hemorrhage/Bleeding (1888); No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 01/10/2024 |
Event Type
malfunction
|
Event Description
|
A sentrant sheath was used during an unknown endovascular procedure.It was reported that during the index procedure when using the sentrant sheath, the hemostatic valve assembly became maladjusted when the dilator was removed causing significant blood loss to the patient.A new sentrant introducer was then used.It was said the blood loss started when the dilater was removed, the hemostatic valve did not maintain hemostasis and was broken.It was confirmed the device appeared normal when inspected prior to use.The patient was fine and no blood transfusion was required , the surgery continued with the new sentrant.No additional sequelae were reported and the patients is fine.
|
|
Manufacturer Narrative
|
Device evaluation summary: a series of five (5) images were received for review.One image captured the shelf carton label confirming the sentrant product identity.The remaining images capture the sentrant sheath with catheter seal, slit seal and the end cap dislodged from the seal housing on the dilator.The reported failure to maintain hemostasis was confirmed through image review.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
B5; additional information received: it was confirmed the blood loss from the sentrant hemostatic valve was less than 50cc and there was no injury to the patient due to this blood loss.Additional information received shows that there is no information to reasonably suggest that the device in this report may have caused or contributed to a serious injury.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|